It’s Time to End Drug-Resistant Tuberculosis
Tuberculosis (TB) is an ancient disease that has killed over 2 billion people in the past 200 years. More recently, drug-resistant strains of TB which are resistant to one or more of the drugs normally used to treat it have emerged and spread. Drug-resistant TB (DR-TB) is the only major airborne drug-resistant epidemic. It is harder and more costly to treat than drug-susceptible TB (DSTB), and affects more than half a million people across the globe annually, mostly in low and middle income countries.
Emerging Antimicrobials and Diagnostics in AMR 2019
International Matchmaking Symposium on 19-20 November, 2019 in Amsterdam, The Netherlands.